3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Brain Neoplasms
4
Neoplasms
3
Prostatic Neoplasms
2
Urogenital Neoplasms
1
Radiation Pneumonitis
1
Radiation Injuries
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Optic Neuritis
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Myelitis, Transverse
1
Myelitis
1
Myasthenia Gravis
1
Lung Neoplasms
1
Lung Diseases, Interstitial
1
Leukemia, Hairy Cell
1
Hematologic Neoplasms
1
Graft vs Host Disease
1
Glioma
1
Genital Neoplasms, Male
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
tocilizumab
2
siltuximab
2
fludarabine phosphate
2
fludarabine
2
Interleukin 1 Receptor Antagonist Protein
2
Cyclophosphamide
2
AP 1903 reagent
2
talquetamab
1
obinutuzumab
1
glofitamab
1
axicabtagene ciloleucel
1
Oxaliplatin
1
Gemcitabine
1
Dexamethasone
1
Calcium Dobesilate
1
Bendamustine Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Cytokine Release Syndrome
×
Adrenal Cortex Hormones
×
1 year
×
Clear all
No trials found.